product summary
Loading...
company name :
MyBioSource
product type :
protein
product name :
Glucokinase, human liver, recombinant
catalog :
MBS845289
quantity :
0.01 mg
price :
200 USD
more info or order :
image
image 1 :
MyBioSource MBS845289 image 1
SPECIFIC ACTIVITY:662 pmol/min/?g. One unit is defined as the amount of enzyme that will convert 1 pmol of NADP to NADPH at 30°C. Assay conditions: 25 mM HEPES, pH 7.5, 2 mM MgCl2, 1.0 mM DTT, 0.5 mM NADP, 2 mM ATP, 25 mM glucose, 100 ?g/ml BSA, 20 units/ml glucose 6-phosphate dehydrogenase, and 10 nM human liver glucokinase at 30°C for 30 min
product information
catalog number :
MBS845289
products type :
Recombinant Protein
products full name :
Glucokinase, human liver, recombinant
products short name :
[Glucokinase]
products name syn :
[Glucokinase; Hexokinase type IV; HK IV; Hexokinase-4; HK4; Hexokinase-D]
other names :
[glucokinase isoform 1; Glucokinase; glucokinase; glucokinase (hexokinase 4); Hexokinase type IV; HK IV; Hexokinase-4; HK4; Hexokinase-D]
products gene name :
[GCK]
other gene names :
[GCK; GCK; GK; GLK; HK4; HHF3; HKIV; HXKP; LGLK; MODY2; FGQTL3; HK IV; HK4]
uniprot entry name :
HXK4_HUMAN
host :
E Coli
sequence length :
465
purity :
>=77% by SDS-PAGE
form :
50 mM potassium phosphate pH 7.4, 50 mM sodium chloride, 0.5 mM DTT, 0.5 mM EDTA, and 2.5% glycerol. Appearance: Liquid
concentration :
1 mg/ml
storage stability :
The protein is best stored in working aliquots at - 80°C. Avoid freeze/thaw cycles. Ships with Dry Ice.
tested application :
SDS-PAGE; HPLC
image1 heading :
Testing Data(TD)
other info2 :
Activity (Specifications/test method): 662 pmol/min/ug. One unit is defined as the amount of enzyme that will convert 1 pmol of NADP to NADPH at 30 degree C. Assay conditions: 25 mM HEPES, pH 7.5, 2 mM MgCl2, 1.0 mM DTT, 0.5 mM NADP, 2 mM ATP, 25 mM glucose, 100 ug/ml BSA, 20 units/ml glucose 6-phosphate dehydrogenase, and 10 nM human liver glucokinase at 30 degree C for 30 min. Unit Definition: One unit is defined as the amount of enzyme that will convert 1 pmol of NADP to NADPH at 30 degree C. Assay conditions: 25 mM HEPES, pH 7.5, 2 mM MgCl2, 1.0 mM DTT, 0.5 mM NADP, 2 mM ATP, 25 mM glucose, 100 ug/ml BSA, 20 units/ml glucose 6-phosphate dehydrogenase, and 10 nM human liver glucokinase at 30 degree C for 30 min. Handling: Centrifuge the vial prior to opening.
products categories :
Proteins and Enzymes; Protein KinasesProteins and Enzymes; Proteins and Enzymes (A-Z) Proteins and Enzymes; Animal-Free Origin (AOF) Recombinant Proteins & EnzymesDiabetes, Obesity & Metabolic Syndrome; Other Products for Diabetes/Obesity Research
products description :
Background: Glucose is phosphorylated to glucose-6-phosphate by glucokinases. This gene is alternatively spliced to generate three different forms of the enzyme; one found in the pancreas and two found in the liver. The main function of this gene is to regulate carbohydrate metabolism. Recombinant human liver Glucokinase (Accession# NP_277042)) has a C-terminal FLAG tag and has 474 amino acid residues. It can be useful for studies including enzyme kinetics, activator screening and kinase selectivity.
ncbi gi num :
4503951
ncbi acc num :
NP_000153.1
ncbi gb acc num :
NM_000162.3
uniprot acc num :
P35557
ncbi mol weight :
53.4 kDa
ncbi summary :
Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. Alternative splicing of this gene results in three tissue-specific forms of glucokinase, one found in pancreatic islet beta cells and two found in liver. The protein localizes to the outer membrane of mitochondria. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. Mutations in this gene have been associated with non-insulin dependent diabetes mellitus (NIDDM), maturity onset diabetes of the young, type 2 (MODY2) and persistent hyperinsulinemic hypoglycemia of infancy (PHHI). [provided by RefSeq, Apr 2009]
uniprot summary :
GK: a glycolytic enzyme that catalyzes glucose metabolism in the liver and pancreatic beta cells. Acts as a glucose sensor in beta cells. The first and rate-limiting step in glycosis, a pathway that produces energy in the form of ATP from glucose. Glucokinase traps glucose inside the cell by catalyzing its phosphorylation to produce glucose-6-phosphate. Has a lower affinity for glucose than the three other isozymes of hexokinase, allowing other organs such as the brain and muscles to have first call on glucose when its supply is limited. Unlike other hexokinases, glucokinase is not inhibited by glucose-6-phosphate. Glucokinase is found in the outer membrane compartment of mitochondria. May bind VDAC, suppressing mitochondrial function. Glucokinase transcription is induced by insulin, perhaps via the activation of Stat 5B. Mutant glucokinase causes a rare form of diabetes and may also play a role in type 2 diabetes. Three splice variant isoforms of human glucokinase have been described. Protein type: Mitochondrial; Carbohydrate Metabolism - starch and sucrose; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Carbohydrate Metabolism - amino sugar and nucleotide sugar; Kinase, other; Carbohydrate Metabolism - galactose; EC 2.7.1.2. Chromosomal Location of Human Ortholog: 7p15.3-p15.1. Cellular Component: nucleoplasm; mitochondrion; actin filament; basal cortex; cytosol; secretory granule. Molecular Function: protein binding; mannokinase activity; magnesium ion binding; fructokinase activity; ADP binding; glucokinase activity; protein phosphatase binding; ATP binding; glucose binding. Biological Process: positive regulation of glycogen biosynthetic process; glucose 6-phosphate metabolic process; lipid homeostasis; pathogenesis; glucose transport; glucose homeostasis; NADP metabolic process; cellular response to glucose starvation; elevation of cytosolic calcium ion concentration; detection of glucose; negative regulation of gluconeogenesis; regulation of glycolysis; transmembrane transport; second-messenger-mediated signaling; glycogen biosynthetic process; glycolysis; regulation of potassium ion transport; glucose metabolic process; positive regulation of insulin secretion; endocrine pancreas development; fructose 2,6-bisphosphate metabolic process; cellular response to insulin stimulus; hexose transport; positive regulation of glycolysis; carbohydrate phosphorylation; carbohydrate metabolic process; negative regulation of epinephrine secretion; cell glucose homeostasis; regulation of insulin secretion; positive regulation of phosphorylation. Disease: Hyperinsulinemic Hypoglycemia, Familial, 3; Diabetes Mellitus, Permanent Neonatal; Maturity-onset Diabetes Of The Young, Type 2; Diabetes Mellitus, Noninsulin-dependent
size1 :
0.01 mg
price1 :
200 USD
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!